Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062947) titled 'Disease burden, unmet needs, and treatment preferences among patients with haemophilia B in Japan: a mixed-methods study incorporating a discrete choice experiment' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - CSL Behring K.K.
Condition:
Condition - Hemophilia B
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To explore how adult patients with haemophilia B in Japan experience their disease and current treatments, including impacts on daily life, treatment burden, and unmet needs.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Diagnosis of haemophilia B confirmed by a physician.
Currently receiving prophylactic treatment for haemophilia B, defined as regular or ongoing therapy intended to prevent bleeding.
18-65 years of age.
Residency in Japan and ability to read and complete study materials in Japanese.
Key exclusion criteria - Participant is unable to provide informed consent.
Patient is not diagnosed with haemophilia B, for example haemophilia A.
Participant is employed by an entity associated with products for coagulation disorders.
Target Size - 62
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 06 Day
Anticipated trial start date - 2026 Year 10 Month 01 Day
Last follow-up date - 2028 Year 01 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071981
Disclaimer: Curated by HT Syndication.
